Read more

May 03, 2022
1 min read
Save

Healthmap secures more funding to pursue kidney care contracts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Investor groups GuideWell and Highmark Ventures led a $35 million funding round for kidney population health management company Healthmap Solutions, according to a company press release.

Eric Reimer

“Caring for members who have kidney disease is complex and costly,” Eric Reimer, Healthmap CEO, said in the release. “For this reason, Healthmap has built a kidney health management solution to be used with our clients to deliver clinical, financial and operational excellence.”

GuideWell is the parent of Florida Blue and Triple-S Management, the Blue Cross Blue Shield plans of Florida and Puerto Rico, while Highmark and its affiliates cover members in Pennsylvania, Delaware, West Virginia and New York, according to the press release.

“This investment from two prominent, Blue-affiliated plans casts a spotlight on a growing public health imperative, to more effectively identify and care for the 40 million people living with kidney disease in the U.S.,” according to the release.

“Our goal is to improve kidney care and reduce costs with new approaches to care,” Saurabh Tripathi, the chief financial officer of Highmark Health, said in the release. “We are excited to work with Healthmap’s proprietary artificial intelligence to build individualized care plans at scale and partner with our network providers to enable them to be more effective and efficient in caring for these complex patients.”

Healthmap will have more than 150,000 members under contract across commercial, Medicare and Medicaid lines of business by the end of the year, according to the release.